Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

SVA

Sernova (SVA)

Sernova Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:SVA
DatumZeitQuelleÜberschriftSymbolFirma
02/06/202217h00PR Newswire (Canada)Sernova Opens the MarketTSXV:SVASernova Corp
10/01/202215h48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
10/01/202215h46PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
10/01/202215h44PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
10/01/202215h41PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
04/02/202116h01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
04/02/202115h58PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
04/02/202115h44PR Newswire (Canada)Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 MillionTSXV:SVASernova Corp
04/02/202115h38PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
04/02/202115h36PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
03/02/202123h20PR Newswire (Canada)Sernova Corp. Announces C$10 Million Bought Deal Offering of UnitsTSXV:SVASernova Corp
15/01/202120h48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
15/01/202120h45PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
15/01/202120h30PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
15/01/202120h27PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
18/06/202018h58InvestorsHub NewsWirePURA SVA - Health Stocks Exhibit Healthy News, Robust Share HikesTSXV:SVASernova Corp
24/10/201913h30PR Newswire (Canada)Sernova Announces Biotech Veteran as New Chief Financial OfficerTSXV:SVASernova Corp
16/10/201918h55InvestorsHub NewsWireSernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-ATSXV:SVASernova Corp
11/04/201918h14InvestorsHub NewsWireSernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical StudyTSXV:SVASernova Corp
05/07/201816h50InvestorsHub NewsWireSernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesTSXV:SVASernova Corp
22/02/201814h35InvestorsHub NewsWireSernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM SystemsTSXV:SVASernova Corp
11/12/201715h03PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
11/12/201715h02PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
11/12/201713h56InvestorsHub NewsWireSernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 DiabetesTSXV:SVASernova Corp
08/12/201720h20PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
08/12/201720h19PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
15/07/201412h00Marketwired CanadaSernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of DiabetesTSXV:SVASernova Corp
24/06/201412h00MarketwiredSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
24/06/201412h00Marketwired CanadaSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
20/06/201412h00MarketwiredSernova's CEO Dr. Philip Toleikis Featured on BNNTSXV:SVASernova Corp
 Showing the most relevant articles for your search:TSXV:SVA